A substance derived from yeast - called Glucose Tolerance Factor (GTF) - has been discovered by University of Haifa researchers to have the potential in becoming an oral treatment for diabetes and its complications.




According to lead researcher Dr. Nitsa Mirsky:

"The substance has been effectively tested on rats and the next step is to assess its efficiency in humans. The research is now at the stage where the substance has been successfully tested on diabetic rats and was found to reduce sugar and lipids in the blood of the treated animals.

The next stage of the research is to evaluate GTF efficacy in humans."

Well, when GTF pass human testing, it will become a treatment as substitute treatment or in conjunction with insulin.

Find more details from University of Haifa.